Open AccessP898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING‐ADJUSTED INDIRECT TREATMENT COMPARISON
Author(s) -
Delforge M.,
Usmani S. Z.,
Donk N. W.,
Garfall A. L.,
Moreau P.,
Oriol A.,
Nooka A. K.,
Rosinol L.,
Bahlis N.,
RodriguezOtero P.,
Martin T.,
Diels J.,
Van Sanden S.,
Pei L.,
Ammann E.,
Kobos R.,
Slavcev M.,
Smit J.,
Londhe A.,
Krishnan A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846464.96684.8e
Subject(s) - medicine , multiple myeloma , refractory (planetary science) , population , oncology , clinical trial , surgery , physics , environmental health , astrobiology